{"nct_id":"NCT07106762","title":"Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy","status":"NOT_YET_RECRUITING","status_verified_date":"2025-09","start_date":"2025-10-22","start_date_type":"ESTIMATED","primary_completion_date":"2029-01-26","primary_completion_date_type":"ESTIMATED","completion_date":"2033-11-18","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["BMY"]}